Interim analysis of a double-blind phase-III clinical trial of adjuvant levamisole versus control in resectable Dukes-C colon cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group
- PMID: 3043583
- DOI: 10.1007/978-3-642-83293-2_14